Unmet medical needs in pulmonary neuroendocrine (carcinoid) neoplasms Review


Authors: Baudin, E.; Hayes, A. R.; Scoazec, J. Y.; Filosso, P. L.; Lim, E.; Kaltsas, G.; Frilling, A.; Chen, J.; Kos-Kudla, B.; Gorbunova, V.; Wiedenmann, B.; van Dijkum, E. N.; Cwikla, J. B.; Falkerby, J.; Valle, J. W.; Kulke, M. H.; Caplin, M. E.; The ENTS 2016 Munich Advisory Board Participants
Contributor: Bodei, L.
Review Title: Unmet medical needs in pulmonary neuroendocrine (carcinoid) neoplasms
Abstract: Pulmonary carcinoids (PCs) display the common features of all well-differentiated neuroendocrine neoplasms (NEN) and are classified as low- and intermediate-grade malignant tumours (i.e., typical and atypical carcinoid, respectively). There is a paucity of randomised studies dedicated to advanced PCs and management principles are drawn from the larger gastroenteropancreatic NEN experience. There is growing evidence that NEN anatomic subgroups have different biology and different responses to treatment and, therefore, should be investigated as separate entities in clinical trials. In this review, we discuss the existing evidence and limitations of tumour classification, diagnostics and staging, prognostication, and treatment in the setting of PC, with focus on unmet medical needs and directions for the future.
Keywords: neoplasms; syndrome; neuroendocrine; prognostic-factors; clinical-features; net; proliferative index; chromogranin-a; cushings-syndrome; somatostatin receptors; enets consensus guidelines; pulmonary carcinoids; european association; receptor radionuclide therapy; bronchial carcinoid tumours; ectopic acth
Journal Title: Neuroendocrinology
Volume: 108
Issue: 1
ISSN: 0028-3835
Publisher: S. Karger AG  
Date Published: 2019-01-01
Start Page: 7
End Page: 17
Language: English
ACCESSION: WOS:000456048400002
DOI: 10.1159/000493980
PROVIDER: wos
PUBMED: 30248673
Notes: Article -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Lisa   Bodei
    205 Bodei